Department of Medicine, University of Auckland, Auckland, New Zealand.
Am J Clin Nutr. 2010 Jan;91(1):82-9. doi: 10.3945/ajcn.2009.28424. Epub 2009 Nov 11.
Vitamin D insufficiency was shown to be associated with adverse musculoskeletal and nonskeletal outcomes in numerous observational studies. However, some studies did not control for confounding factors such as age or seasonal variation of 25-hydroxyvitamin D [25(OH)D].
We sought to determine the effect of vitamin D status on health outcomes.
Healthy community-dwelling women (n = 1471) with a mean age of 74 y were followed in a 5-y trial of calcium supplementation. 25(OH)D was measured at baseline in all women. Skeletal and nonskeletal outcomes were evaluated according to seasonally adjusted vitamin D status at baseline.
Fifty percent of women had a seasonally adjusted 25(OH)D concentration <50 nmol/L. These women were significantly older, heavier, and less physically active and had more comorbidities than women with a seasonally adjusted 25(OH)D concentration > or =50 nmol/L. Women with a seasonally adjusted 25(OH)D concentration <50 nmol/L had an increased incidence of stroke and cardiovascular events that did not persist after adjustment for between-group differences in age or comorbidities. Women with a seasonally adjusted 25(OH)D concentration <50 nmol/L were not at increased risk of adverse consequences for any musculoskeletal outcome, including fracture, falls, bone density, or grip strength or any nonskeletal outcomes, including death, myocardial infarction, cancer, heart failure, diabetes, or adverse changes in blood pressure, weight, body composition, cholesterol, or glucose.
Vitamin D insufficiency is more common in older, frailer women. Community-dwelling older women with a seasonally adjusted 25(OH)D concentration <50 nmol/L were not at risk of adverse outcomes over 5 y after control for comorbidities. Randomized placebo-controlled trials are needed to determine whether vitamin D supplementation in individuals with vitamin D insufficiency influences health outcomes. This trial was registered at www.anzctr.org.au as ACTRN 012605000242628.
多项观察性研究表明,维生素 D 不足与肌肉骨骼和非骨骼不良结局有关。然而,一些研究并未控制 25-羟维生素 D [25(OH)D]的年龄或季节性变化等混杂因素。
我们旨在确定维生素 D 状况对健康结果的影响。
1471 名平均年龄为 74 岁的健康社区居住女性参与了为期 5 年的补钙试验。所有女性均在基线时测量 25(OH)D。根据基线时季节性调整的维生素 D 状况评估骨骼和非骨骼结局。
50%的女性有季节性调整的 25(OH)D 浓度<50nmol/L。与 25(OH)D 浓度≥50nmol/L 的女性相比,这些女性年龄较大、体重较重、身体活动较少且合并症更多。25(OH)D 浓度<50nmol/L 的女性中风和心血管事件的发生率增加,但在调整组间年龄或合并症差异后,这种增加并不持续。25(OH)D 浓度<50nmol/L 的女性发生任何骨骼不良结局的风险(包括骨折、跌倒、骨密度或握力)或任何非骨骼不良结局(包括死亡、心肌梗死、癌症、心力衰竭、糖尿病或血压、体重、身体成分、胆固醇或血糖的不良变化)的风险均未增加。
维生素 D 不足在年龄较大、身体较虚弱的女性中更为常见。在控制合并症后,5 年内,25(OH)D 浓度季节性调整<50nmol/L 的社区居住老年女性发生不良结局的风险不高。需要随机安慰剂对照试验来确定维生素 D 不足个体补充维生素 D 是否会影响健康结果。该试验在 www.anzctr.org.au 注册,注册号为 ACTRN 012605000242628。